If you have ever avoided a sunscreen because of the oxybenzone or octinoxate on the label, the FDA just handed you a real, official reason to expect better options later this year. On June 9, 2026, the agency issued a final order approving bemotrizinol, sold under the brand name PARSOL Shield, as a new active sunscreen ingredient, the first new UV filter approved in the US in more than two decades.
Bemotrizinol absorbs both UVA and UVB radiation, true broad spectrum protection, and has a track record of low percutaneous absorption relative to several chemical filters already sold in the US, like oxybenzone. That absorption profile is a big part of why clean beauty and mineral sunscreen advocates have pushed for its approval for years. It has already been used safely in sunscreens across Europe and Asia for a long time, so the FDA's review is really about catching US regulation up to what other markets already allow.
The FDA's proposed order was issued December 12, 2025, cleared public comment by January 26, 2026, and was finalized June 9, 2026. Reporting on the approval has been consistent across outlet types, an official FDA press release, general news coverage, and trade chemistry press, with no conflicting details. DSM Firmenich holds exclusive US marketing rights for the ingredient for its first 18 months, so it will not show up in every brand's formula right away.
Nothing containing bemotrizinol is legally sellable in the US until the order takes effect on August 9, 2026, so there is nothing on shelves to buy yet, and the exclusivity window means early availability will be limited to whichever brands license it first. A better absorption profile than oxybenzone is an industry and regulatory characterization, not a claim of zero risk. No UV filter, including bemotrizinol, has long term safety data at the scale of decades of oxybenzone use, so treat "better tolerated" as a real but relative claim.
If you already avoid oxybenzone based sunscreens over absorption concerns but dislike the white cast that comes with fully mineral formulas, this is a legitimate reason to watch for new options later this year rather than assume nothing is changing. Just do not expect to find it in stores this summer. The realistic timeline is later in 2026 at the earliest, and only from whichever brands DSM Firmenich licenses first.
Not yet. The FDA order does not legally take effect until August 9, 2026, and one company holds exclusive US marketing rights for the ingredient for the first 18 months after that, so early availability will be limited to whichever brands license it first.
It has a lower percutaneous absorption profile than some existing US chemical filters like oxybenzone, which is a real advantage, but no UV filter, including bemotrizinol, has decades of long term safety data the way older filters do. Better absorption profile is not the same as zero risk.
No. Bemotrizinol is a chemical filter, not a mineral one, so it is really a new option within the chemical sunscreen category rather than a replacement for zinc oxide or titanium dioxide based products.
Get the Daily Signal in your inbox each morning, verified and no hype, before you even open your phone.